Wave Life Sciences Ltd. — Director's Dealing 2017

Feb 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2017-02-01

Reporting Person: Rawcliffe Adrian (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-02-01	Share Option (right to buy)	$28.80	A	18000	Acquired	2022-02-01	Ordinary Shares (18000)	Direct

Footnotes

F1: The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy.The option vests as to 25% of the shares on February 1, 2018 and vests as to an additional 2.0833% of the shares monthly thereafter until February 1, 2021.